CD44 and non-small cell lung carcinoma: A study reported by Thangavel et al. used indocyanine green–paclitaxel encapsulated in human serum albumin nanoparticles that were functionalized with hyaluronic acid, as a ligand for drug delivery with image guiding capability directed to CD44 non-small cell lung cancer (NSCLC).